Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Johnson & Johnson

< Previous 1 2 3 4 Next >
Johnson & Johnson Subsidiary LTL Management LLC (“LTL”) Re-Files for Voluntary Chapter 11 to Equitably Resolve All Current and Future Talc Claims
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Pricing of $7.75 Billion of Senior Notes Issued by Kenvue Inc.
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Barclays Global HealthCare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Appoints Dr. John Reed as Executive Vice President, Pharmaceuticals, R&D
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2023
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Completes Acquisition of Abiomed
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Acquire Abiomed
From Johnson & Johnson
Via Business Wire
Tickers ABMD JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2022
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q3 2022 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces $5 Billion Share Repurchase Program
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q2 2022 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022
From Johnson & Johnson
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback